HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
This Quarter Return
+12.07%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.74B
AUM Growth
–
Cap. Flow
+$1.74B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
29.01%
Holding
178
New
178
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$61.2M |
| 2 |
UnitedHealth
UNH
|
$57.4M |
| 3 |
Zoetis
ZTS
|
$49.2M |
| 4 |
AstraZeneca
AZN
|
$48.7M |
| 5 |
Merck
MRK
|
$48.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 54.59% |
| 2 | Technology | 16.36% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 5.78% |
| 5 | Communication Services | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$429B
| $61.2M | 3.52% |
+346,707
| New | +$61.2M |
|
|
2
UnitedHealth
UNH
$280B
| $57.4M | 3.3% |
+108,275
| New | +$57.4M |
|
|
3
Zoetis
ZTS
$67.9B
| $49.2M | 2.83% |
+335,987
| New | +$49.2M |
|
|
4
AstraZeneca
AZN
$250B
| $48.7M | 2.8% |
+718,193
| New | +$48.7M |
|
|
5
Merck
MRK
$212B
| $48.6M | 2.79% |
+437,740
| New | +$48.6M |
|
6
AbbVie
ABBV
$372B
| $48.3M | 2.78% |
+299,120
| New | +$48.3M |
|
7
Thermo Fisher Scientific
TMO
$183B
| $47.9M | 2.75% |
+86,909
| New | +$47.9M |
|
8
Abbott
ABT
$230B
| $47.8M | 2.75% |
+435,715
| New | +$47.8M |
|
9
Intuitive Surgical
ISRG
$169B
| $47.8M | 2.75% |
+180,127
| New | +$47.8M |
|
10
Stryker
SYK
$149B
| $47.6M | 2.74% |
+194,707
| New | +$47.6M |
|
11
Boston Scientific
BSX
$157B
| $47.3M | 2.72% |
+1,021,516
| New | +$47.3M |
|
12
Pfizer
PFE
$142B
| $47M | 2.7% |
+917,358
| New | +$47M |
|
13
Novartis
NVS
$245B
| $46.9M | 2.7% |
+517,129
| New | +$46.9M |
|
14
Danaher
DHR
$146B
| $46.5M | 2.67% |
+175,233
| New | +$46.5M |
|
15
Eli Lilly
LLY
$653B
| $46.3M | 2.66% |
+126,548
| New | +$46.3M |
|
16
Amgen
AMGN
$155B
| $44.1M | 2.53% |
+167,861
| New | +$44.1M |
|
17
Regeneron Pharmaceuticals
REGN
$61.4B
| $42.9M | 2.47% |
+59,463
| New | +$42.9M |
|
18
Bristol-Myers Squibb
BMY
$96.9B
| $42.3M | 2.43% |
+588,165
| New | +$42.3M |
|
19
Elevance Health
ELV
$72.7B
| $41.7M | 2.4% |
+81,386
| New | +$41.7M |
|
20
Medtronic
MDT
$120B
| $39.4M | 2.27% |
+507,240
| New | +$39.4M |
|
21
Visa
V
$679B
| $29.7M | 1.71% |
+142,783
| New | +$29.7M |
|
22
Microsoft
MSFT
$3.74T
| $28.5M | 1.64% |
+118,804
| New | +$28.5M |
|
23
Accenture
ACN
$160B
| $27.1M | 1.56% |
+101,708
| New | +$27.1M |
|
24
Intel
INTC
$105B
| $27M | 1.55% |
+1,020,125
| New | +$27M |
|
25
Alphabet (Google) Class A
GOOGL
$2.52T
| $25M | 1.44% |
+283,300
| New | +$25M |
|